The drug substance and drug product are manufactured at the Spark Therapeutics, Inc. facility located in Philadelphia, PA. This facility is designed and operated in accordance with current Good Manufacturing Practices (cGMP) for the production of biological and gene therapy products. All equipment is fully qualified and validated for its intended use.